Please find enclosed the certificates received from the registrar and share transfer agent of the Company under Regulation 74(5) of SEBI (Depositories And Participants) Regulations, 2018 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has submitted to BSE the Regulation 74(5) certificates issued by its Registrar & Share Transfer Agent, KFIN Technologies Limited, for the quarter ended June 30, 2025. Separate confirmations were received from both NSDL and CDSL, certifying that the details of shares dematerialized and rematerialized during the quarter have been furnished to the stock exchanges. The communication was signed by Nirav Shah, Company Secretary & Compliance Officer. This is a routine quarterly compliance filing with no new financial or business disclosures.
This is a standard regulatory compliance submission and has no direct impact on the company's financials, operations, or stock price. It simply confirms that the registrar has reported demat/remat activity to the exchanges, as required by SEBI rules.